Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies. 1985

E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova

An experimental study of several types of vaccines against Pseudomonas aeruginosa has been carried out. Pyoimmunogen, a multi-component vaccine consisting mainly of heat-stable proteins (or polypeptides) with a molecular weight of 20 000 to 60 000, was prepared both by laboratory and production techniques using three or five selected strains of P. aeruginosa. The preparations obtained by both methods were found to be of low toxicity and to induce in mice and rats active immunity against challenge with homologous and some heterologous strains of P. aeruginosa, including the toxigenic PA-103 strain. The Pseudomonas vaccine (PV) was prepared from partly purified water-soluble protein antigens (molecular weight ranging from 10 000 to 100 000) obtained from one (mono-PV) or three (tri-PV) selected strains. Mono-PV was prepared by the method of ultrafiltration and tri-PV--by differential centrifugtion. Both types of vaccines proved effective in active mouse protection tests after challenge with homologous as well as with heterologous P. aeruginosa strains. Mono-PV is supposed to induce species-specific immunity against P. aeruginosa infection in mice.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D011749 Pyrogens Substances capable of increasing BODY TEMPERATURE and cause FEVER and may be used for FEVER THERAPY. They may be of microbial origin, often POLYSACCHARIDES, and may contaminate distilled water. Pyrogen
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001428 Bacterial Vaccines Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease. Bacterial Vaccine,Bacterin,Vaccine, Bacterial,Vaccines, Bacterial
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
September 1985, Vaccine,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
February 2008, Vaccine,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
September 1972, Nihon saikingaku zasshi. Japanese journal of bacteriology,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
January 1989, Contributions to microbiology and immunology,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
January 1983, Reviews of infectious diseases,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
January 2015, Human vaccines & immunotherapeutics,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
December 1972, British journal of experimental pathology,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
July 2003, FEMS immunology and medical microbiology,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
May 1983, Infection and immunity,
E S Stanislavsky, and I Joo, and G M Mashilova, and V F Boolk, and L G Boltutsy, and D A Zakgeim, and M K Severtśova, and L S Yedvabnaya, and M A Gladus, and T I Fatkhinurova
May 1982, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
Copied contents to your clipboard!